Although the potential impact on overall tumor size remains a consideration, our results indicate that CXCR4 blockade can directly reduce the degree of jawbone destruction by inhibiting the activity of osteoclasts, and can also reduce the expression of EMT-related proteins, thereby acting on the EMT process to reduce the metastatic and invasive potential of OSCC. Here, CXCR4 is linked to neoplasm.